What type of study is this?

This is a Validation Study study.

What question did this study set out to answer?

This work explores the innovations and challenges in utilizing tumor organoids for cancer research and clinical applications.

December 14, 2025Med ResearchOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Editorial reveals clinical decision-making advances using tumor organoids, highlighting their role in drug screening and AI.

This work explores the innovations and challenges in utilizing tumor organoids for cancer research and clinical applications.
Discussion of patient-derived organoid technology advancements
Integration of microfluidic chips and AI for drug screening
Examination of immune co-culture models and therapy resistance
Tumor organoids enable accurate disease modeling by preserving genetic heterogeneity
Novel platforms are available for testing immune interactions
AI and high-throughput screening drastically improve drug efficacy predictions

Wu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark